TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 6 | 2 | 5 | 6 | 1 | -13 | -21 | -3 |
| P | %wins | 50 | 67 | 83 | 33 | 20 | 20 | 46 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/14 08:40 | 11/5/14 | PDII | Pdi Inc | BizSv | BizSv | Business Services | Belle Gerald P. | NJ | D | P | 98 | 1.71 | 0 | 57 | 29 | 253 | I | -77 | -71 | -69 | -63 | -39 | -21 | -12 | -19 | 14 | 25 | 9 | 12 | -10 | -5 | ||
11/19/13 13:15 | 11/15/13 | PDII | Pdi Inc | BizSv | BizSv | Business Services | Belle Gerald P. | NJ | D | P.m | 106 | 5.21 | 0 | 20 | 16 | 148 | D | -20 | -12 | 13 | 13 | 16 | 3 | 8 | 2 | -1 | -2 | -8 | -4 | -14 | -68 | ||
5/17/12 17:10 | 5/15/12 | MYRX | Myrexis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Belle Gerald P. | UT | D | P.m | 100 | 2.74 | 0 | 37 | 90 | 77 | D | |||||||||||||||
11/25/11 16:07 | 11/22/11 | MYRX | Myrexis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Belle Gerald P. | UT | D | P.m | 100 | 2.48 | 0 | 40 | 999% | 41 | D | -52 | -32 | -37 | -7 | -8 | -7 | -4 | 2 | 3 | 6 | 11 | 27 | |||
11/19/10 14:55 | 11/18/10 | PDII | Pdi Inc | BizSv | BizSv | Business Services | Belle Gerald P. | NJ | D | P | 11 | 10.60 | 0 | 1 | 1 | 68 | D | 149 | 163 | 39 | 42 | 20 | 21 | 10 | -1 | -2 | -4 | 6 | -15 | -35 | -40 | ||
8/12/09 15:10 | 8/11/09 | PDII | Pdi Inc | BizSv | BizSv | Business Services | Belle Gerald P. | NJ | D | P | 5 | 5.21 | 0 | 1 | 2 | 51 | D | -50 | -35 | -9 | 49 | 24 | 14 | -2 | 0 | 0 | 4 | 2 | -3 | 5 | 48 | ||
5/7/09 17:30 | 5/7/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Belle Gerald P. | UT | D | P | 33 | 32.50 | 33 | 1 | 500 | 1 | D | 66 | 57 | 4 | -22 | -27 | -29 | -15 | -15 | -5 | 1 | 15 | -10 | -12 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |